Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Sep;73(9):1571-1573.
doi: 10.1002/art.41801. Epub 2021 Aug 9.

Few Adverse Cardiovascular Events Among Patients With Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?

Candace H Feldman  1 , Mark S Link  2
Affiliations
Editorial

Few Adverse Cardiovascular Events Among Patients With Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured?

Candace H Feldman et al. Arthritis Rheumatol. 2021 Sep.
No abstract available

PubMed Disclaimer

Comment on

  • Cardiovascular Safety of Hydroxychloroquine in US Veterans With Rheumatoid Arthritis.
    Faselis C, Zeng-Treitler Q, Cheng Y, Kerr GS, Nashel DJ, Liappis AP, Weintrob AC, Karasik PE, Arundel C, Boehm D, Heimall MS, Connell LB, Taub DD, Shao Y, Redd DF, Sheriff HM, Zhang S, Fletcher RD, Fonarow GC, Moore HJ, Ahmed A. Faselis C, et al. Arthritis Rheumatol. 2021 Sep;73(9):1589-1600. doi: 10.1002/art.41803. Epub 2021 Aug 6. Arthritis Rheumatol. 2021. PMID: 33973403

References

    1. World Health Organization. The cardiotoxicity of antimalarials: WHO Evidence Review Group meeting, 13-14 October 2016 Varembe Conference Centre, Geneva, Switzerland. March 2017. URL: https://www.who.int/malaria/mpac/mpac-mar2017-erg-cardiotoxicity-report-....
    1. Hooks M, Bart B, Vardeny O, Westanmo A, Adabag S. Effects of hydroxychloroquine treatment on QT interval. Heart Rhythm 2020;17:1930-5.
    1. Mercuro NJ, Yen CF, Shim DJ, Maher TR, McCoy CM, Zimetbaum PJ, et al. Risk of QT interval prolongation associated with use of hydroxychloroquine with or without concomitant azithromycin among hospitalized patients testing positive for coronavirus disease 2019 (COVID-19). JAMA Cardiol 2020;5:1036-41.
    1. Singh AP, Tousif S, Umbarkar P, Lal H. A pharmacovigilance study of hydroxychloroquine cardiac safety profile: potential implication in COVID-19 mitigation. J Clin Med 2020;9:1867.
    1. Yang DH, Leong PY, Sia SK, Wang YH, Wei JC. Long-term hydroxychloroquine therapy and risk of coronary artery disease in patients with systemic lupus erythematosus. J Clin Med 2019;8:796.

MeSH terms

LinkOut - more resources